EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing Cardiomyocyte Maturation: Current Strategies and Promising Conductive Polymer‐Based Approaches

Kamil Elkhoury iD, Sacha Kodeih, Eduardo Enciso-Martínez, Ali Maziz, Christian Bergaud iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202303288 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Kamil Elkhoury und 4 weiteren Autor:innen. Beteiligte Einrichtung: LAAS-CNRS, Université de Toulouse, CNRS, Toulouse, F-31400, France. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Polymers. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU Horizon 2020 Framework Programme (H2020).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases are a leading cause of mortality and pose a significant burden on healthcare systems worldwide. Despite remarkable progress in medical research, the development of effective cardiovascular drugs has been hindered by high failure rates and escalating costs. One contributing factor is the limited availability of mature cardiomyocytes (CMs) for accurate disease modeling and drug screening. Human induced pluripotent stem cell‐derived CMs offer a promising source of CMs; however, their immature phenotype presents challenges in translational applications. This review focuses on the road to achieving mature CMs by summarizing the major differences between immature and mature CMs, discussing the importance of adult‐like CMs for drug discovery, highlighting the limitations of current strategies, and exploring potential solutions using electro‐mechano active polymer‐based scaffolds based on conductive polymers. However, critical considerations such as the trade‐off between 3D systems and nutrient exchange, biocompatibility, degradation, cell adhesion, longevity, and integration into wider systems must be carefully evaluated. Continued advancements in these areas will contribute to a better understanding of cardiac diseases, improved drug discovery, and the development of personalized treatment strategies for patients with cardiovascular disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacPolymersHumansInduced Pluripotent Stem CellsAnimalsTissue ScaffoldsCell DifferentiationCardiovascular DiseasesTissue Engineering

Stichwörter der Autor:innen

cardiomyocyte maturationcardiovascular researchconductive polymershuman induced pluripotent stem cellsphysiological stimuli

Substanzen

Polymers

Autor:innen und Institutionen

  • LAAS-CNRS, Université de Toulouse, CNRS, Toulouse, F-31400, France.
  • Faculty of Medicine and Medical Sciences, University of Balamand, Tripoli, P.O. Box 100, Lebanon.
  • School of Engineering and Sciences, Tecnológico de Monterrey, Nuevo León, 64849, México.

ORCID-Profile: Kamil Elkhoury, Christian Bergaud

Förderung

  • EU Horizon 2020 Framework Programme (H2020)

Zitieren

APA

Elkhoury, K., Kodeih, S., Enciso-Martínez, E., Maziz, A., & Bergaud, C. (2024). Advancing Cardiomyocyte Maturation: Current Strategies and Promising Conductive Polymer‐Based Approaches. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303288

Vancouver

Elkhoury K, Kodeih S, Enciso-Martínez E, Maziz A, Bergaud C. Advancing Cardiomyocyte Maturation: Current Strategies and Promising Conductive Polymer‐Based Approaches. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303288

BibTeX
@article{Elkhoury2024,
  author = {Elkhoury, Kamil and Kodeih, Sacha and Enciso-Martínez, Eduardo and Maziz, Ali and Bergaud, Christian},
  title = {Advancing Cardiomyocyte Maturation: Current Strategies and Promising Conductive Polymer‐Based Approaches},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202303288}
}
Kostenlos starten →